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Kajian Farmakologi dan Pembangunan Kultur Tisu bagi Tumbuhan Hymenocallis 
littoralis 
 
ABSTRAK 
Hymenocallis littoralis merupakan sejenis pokok hiasan yang mempamerkan 
pelbagai aktiviti terapeutik seperti aktiviti anti-Candida, antioksidan, sitotoksiti dan 
penyembuhan luka. Sehubungan itu, bahagian-bahagian pokok ini seperti anter, batang, 
umbisi, bunga, daun dan akar telah diekstrak menggunakan methanol melalui kaedah 
sonikasi. Kajian aktiviti anti-Candida telah dijalankan dengan menggunakan ekstrak 
pokok ini ke atas yis Candida albicans (ATCC 10231). Ekstrak metanol bagi bunga dan 
akar pokok ini mempamerkan aktiviti anti-Candida yang baik pada 6.25 mg/mL sebagai 
kepekatan perencatan minimum (MIC). Analisis oleh mikroskop elektron pengimbasan 
dan transmisi berjaya mendedahkan bahawa sel Candida telah kehilangan integriti 
dinding sel dan kandungan nukleusnya selepas 36 jam dirawat dengan menggunakan 
ekstrak berkenaan. Ekstrak metanol bagi bunga dan anter menunjukkan kuasa 
antioksidan penurunan ferric (FRAP) pada 555.12 ± 1.67 dan 568.09 ± 0.42 µmol 
(Fe2
+
)/g. Selain FRAP, ujian 2,2-diphenyl-1-picrylhydrazyl (DPPH) yang telah 
dijalankan menunjukkan bahawa kepekatan perencatan pada kadar 50 % (IC50) bagi 
bunga: 1.29 mg/mL, daun: 5.07 mg/mL, batang: 1.33 mg/mL, umbisi: 5.42 mg/mL, 
akar: 3.68 mg/mL dan anter: 0.31 mg/mL. Akhirnya, kandungan fenolik dan flavonoid 
daripada semua ekstrak telah dianalisis. Kandungan fenolik secara meningkat 
terkandung dalam akar < daun < batang < umbisi < bunga < anter, manakala kandungan 
xxiii 
 
flavonoid pula adalah pada umbisi < akar < daun < bunga < batang < anter. Penemuan 
ini menunjukkan bahawa ekstrak metanol bagi anter mempamerkan aktiviti antioksidan 
yang lebih baik berbanding semua ekstrak lain dan mempunyai kandungan fenolik dan 
flavonoid yang tinggi. Ujian kematian udang air garam telah dijalankan bagi mengetahui 
aktiviti sitotoksiti dan ekstrak metanol bagi daun menunjukkan 100 % kematian terhadap 
kesemua anak udang selepas 12 jam menjalani ujian. Kepekatan kematian (LC 50) 
median telah dikira dan ianya menunjukkan nilai sebanyak 8.50 µg/mL bagi umbisi, 
11.73 µg/mL bagi akar, 15.95 µg/mL bagi anter, 16.92 µg/mL bagi batang dan sebanyak 
64.58 µg/mL bagi bunga. Ekstrak metanol bagi daun dan akar mempunyai aktiviti 
sitotoksiti yang kuat. Aktiviti farmakologi kemudiannya difokuskan pula kepada 
kandungan bahan-bahan penyembuhan luka. Didapati, ekstrak daripada umbisi, akar, 
batang, dan anter mempunyai aktiviti penyembuhan luka yang aktif pada kepekatan 1 
µg/mL selepas 36 jam menjalani ujian. Oleh kerana ekstrak pokok ini mempamerkan 
aktiviti farmakologi yang menonjol, teknik mikropropagasi in vitro telah digunakan 
untuk manghasilkan kalus dan pucuk tumbuhan Hymenocallis littoralis menggunakan 
kombinasi 2,4-Dichlorophenoxyacetic acid (2,4-D) dan Benzylaminopurine (BAP) pada 
kepekatan yang ditetapkan. Kepekatan 13.5 µM 2,4-D dan 4.5 µM BAP telah dikenal 
pasti untuk menginduksikan kalus pada masa yang tersingkat dalam peratusan yang 
tertinggi. Kombinasi dan kepekatan hormon ini berjaya untuk membentuk kalus dalam 
hanya 15 hari di samping menghasilkan 93.75% kalus. Hormon 2,4-D pada kepekatan 
13. 5 µM mengambil masa selama 10 hari untuk meghasilkan pucuk tumbuhan dengan 
ketinggian 6.2 cm manakala hormone BAP pula pada kepekatan yang sama mampu 
menghasilkan 4.2 pucuk tumbuhan daripada satu tisu meristem umbisi yang digunakan. 
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Ekstrak ini seterusnya digunakan dalam analisis kromotografi cecair berprestasi tinggi 
(HPLC) menggunakan kaedah ultraungu (UV) untuk mengesahkannya. Lycorine telah 
digunakan sebagai penanda dalam proses pengesahan ini. Had pengesanan (LOD) HPLC 
adalah pada 24.41 ng/mL dan had kuantifikasi (LOQ) adalah pada bacaan 195.31 
µg/mL. Ketepatan dan kejituan proses pengesahan tersebut pada ujian antara hari adalah 
diantara 95.4 % dan 104.7 % manakala ujian dalam tempoh sehari adalah diantara 0.7 % 
and 8.2 %. Kandungan lycorine telah dianggarkan menggunakan kaedah pengesahan 
HPLC dan ianya menunjukkan bahawa umbisi (2.54 ± 0.02 µg/mg), bunga (2.43 ± 0.17 
µg/mg) dan anter (2.13 ± 0.35 µg/mg) mempunyai kandungan yang tinggi. Kultur kalus 
in vitro yang dihasilkan menggunakan hormon  2,4-D (4.5 µM) sahaja menunjukkan 
kandungan lycorine yang tertinggi (2.58 ± 0.35 µg/mg) manakala kultur kalus dengan 
kombinasi dan kepekatan  2,4-D (4.5 µM) dan  BAP (4.5 µM) menunjukkan kandungan 
lycorine sebanyak 2.45 ± 0.15 µg/mg. Penemuan ini membuktikan bahawa 
pembentukkan kalus secara in vitro mampu memberikan jumlah lycorine yang setanding 
berbanding pokok liar. Pembentukkan kalus mengunakan teknik mikropropagasi ini 
adalah sangat cekap kerana penggandaannya yang pesat dan mempunyai kandungan 
genetik yang hampir sama dengan pokok liar. Penemuan ini berjaya membuktikan 
kepentingan terapeutik pokok hiasan Hymenocallis littoralis dalam bidang 
farmaseutikal. Oleh itu, penemuan ini dapat membantu dalam pembentukkan ejen anti-
Candida, antioksidan dan antikanser yang murah dan lebih berkesan. 
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Pharmacological Studies and Establishment of Tissue Culture for 
Hymenocallis littoralis  
ABSTRACT 
Hymenocallis littoralis an ornamental plant exhibits numerous therapeutic 
properties such as anti-Candida, antioxidant, cytotoxicity and wound healing activities. 
Hymenocallis littoralis parts including anther, bulb, flower, leaves, stem and roots were 
extracted via sonication technique using methanol solvent. The wild plant extracts was 
subjected to anti-Candida activity and it shows promising activity against Candida 
albicans strain (ATCC 10231).  The flower and root methanolic extracts exhibits better 
anti-Candida activity at 6.25 mg/mL as minimum inhibitory concentration (MIC). 
Scanning and transmission electron microscopy analysis reveals the cells lost its cell 
wall contact integrity and also nucleus properties at 36 h of treatment. The flower and 
anther methanolic extracts shows ferric reducing antioxidant power (FRAP) at 555.12 ± 
1.67 and 568.09 ± 0.42 µmol (Fe2
+
)/g. Beside FRAP, 2,2-diphenyl-1-picrylhydrazyl 
(DPPH) assay carried out and it expresses inhibitory concentration at 50 % (IC50) for 
flower: 1.29 mg/mL, leaves: 5.07 mg/mL, stem: 1.33 mg/mL, bulb: 5.42 mg/mL, root: 
3.68 mg/mL and anther 0.31 mg/mL. Finally, the phenolic and flavonoid contents of all 
the extracts were analyzed. The phenolic content in ascending order was root < leaves < 
stem < bulb < flower < anther, while flavonoid content was bulb < root < leaves < 
flower < stem < anther. In conclusion, the methanolic extract of anther exhibits better 
antioxidant activity with high amount of phenolic and flavonoid contents. Brine shrimp 
lethality assay was carried out to determine the cytotoxicity activity and the methanolic 
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leaves extract exhibits 100 % death for all the nauplii at 12 h of treatment point. The 
median lethality concentration (LC 50) was analyzed and the LC 50 concentration for 
bulb, root, anther, stem and flower are 8.50 µg/mL, 11.73 µg/mL, 15.95 µg/mL, 16.92 
µg/mL and 64.58 µg/mL, respectively. Leaves and bulb methanolic extracts have strong 
cytotoxicity activity. The pharmacology activity was further carried out to focus on 
wound healing properties. Interestingly, the bulb, root, stem and anther methanolic 
extracts demonstrated active wound healing activity at 1 µg/mL at 36 h of treatment. 
Since the wild plant extract exhibits prominent pharmacological activities, in vitro 
micro-propagation techniques was carried out to establish callus and shoots production 
by using combinations of 2,4-Dichlorophenoxyacetic acid (2,4-D) and 
Benzylaminopurine (BAP) hormones at different concentrations. Highest percentage and 
earliest induction of callus was observed from 13.5 µM of 2,4-D and 4.5 µM of BAP 
treatment with 93.75 % of callus induction at 15
th
 day. The 2,4-D hormone at 13. 5 µM 
concentrations induced shoot at earlier time period (10
th
 day) with length of 6.2 cm. 
Meanwhile, BAP at 13.5 µM produced higher number of shoots with the average of 4.2 
shoots per bulb meristematic tissue. Subsequently, the extracts were subjected to high 
performance liquid chromatography (HPLC) ultraviolet (UV) analysis to validate the 
extracts with lycorine. The limit of detection (LOD) and limit of quantification (LOQ) of 
lycorine was 24.41 ng/mL and 195.31 µg/mL. The accuracy and precision of the 
validation for between-day and within day was between 95.4 % and 104.7 % and 
between 0.7 % and 8.2 % respectively. The content of lycorine compound was estimated 
through HPLC validation method and it demonstrated that the bulb (2.54 ± 0.02 µg/mg), 
flower (2.43 ± 0.17 µg/mg) and anther (2.13 ± 0.35 µg/mg) to have high amount of 
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lycorine content in wild plant extracts. In vitro callus initiated through best combination 
hormones of 4.5 µM of 2,4-D and 0 µM of BAP has highest amount of lycorine content 
at 2.58 ± 0.35 µg/mg and  4.5 µM of 2,4-D and 4.5 µM BAP combination displays 2.45 
± 0.15 µg/mg of lycorine. In vitro callus establishment technique express comparable 
amount of lycorine as wild plant extracts. The micropropagation technique are very 
efficient for callus production because of the rapid propagation with genetically alike 
properties as wild plant. These findings prove the therapeutic importance of an 
ornamental plant in pharmaceuticals facet. These could aid in the development of new 
cost effective and proficient anti-Candida, antioxidant and anti-proliferation agents.   
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CHAPTER 1.0 
GENERAL INTRODUCTION 
 
 Plants, plant parts, and isolated phytochemicals are widely used for the 
prevention and treatment of various health ailments from time immemorial (Sahoo et 
al., 2010). Demand for herbal medicines, herbal health products, nutraceuticals, food 
supplements, herbal pharmaceuticals and cosmetics are increasing globally (Sen et 
al., 2011). This is all contributed to the recognition of these products as mainly non-
toxic, less side effects, better compatibility with physiological flora and availability 
at affordable price (Dubey et al., 2004).  
 Plants have a great history as the basis of potential therapeutic agents with 
evidences of plant secondary metabolites such as reserpine, vinblastine, vincristine, 
taxol, ginkgolides, lectinan, deserpidine, morphine, codeine incorporated into 
modern medicine (Mukherjee et al., 2010). Thus, approximately 5-15 % of the total 
250 000 species of higher plants have been systematically investigated and identified 
to be a good source of novel bioactive compounds (Cragg and Newman, 2005).  
Spider lily or scientifically known as Hymenocallis littoralis is one of the 
well-known plant species for its medicinal properties. Hymenocallis littoralis is 
grouped under Amaryllidaceae family. This plant species has high amount of 
alkaloidal content. As been reviewed by Abou-Donia et al., (2008a) Hymenocallis 
salisb genus was first phytochemically studied in 1920, which resulted in the 
isolation of lycorine (alkaloid). Numbers of alkaloids such as lycorine, narciclasine, 
lycoricidine (bulb), pancratistatin (bulb and roots in small extent), trisphaeridine and 
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others were isolated from this plant (Lin et al., 1995). This plant has antineoplastic, 
antiviral activity (Renard-Noiaki et al., 1989), cytotoxicity for 60 human cancer cell 
lines (Pettit et al., 1993a) and antitumor properties (Idso et al., 2000). Therefore, to 
explore more on the pharmacological effects, antifungal, antioxidant, wound healing 
activities and brine shrimp toxicity studies of this plant were explored. Moreover, 
establishment of plant tissue culture system in Hymenocallis littoralis also was 
carried out this study.  
Most of the immune-compromised patients become victim for the fungal 
infection. Candida spp. are the most common pathogens that kills immune-
compromised patients (Yigit et al., 2008). The candidiasis infection is often severe, 
rapidly progressive, difficult to diagnose and refractory to therapy (Yigit et al., 
2008). Among the various species, Candida albicans is the dangerous causative 
agent associated with serious fungal infections (Edwards, 1995; Douglas, 2003; 
Naeini et al., 2009).  There are numerous problems in the management of the 
invasive fungal infection due to modern medicines (Naeini et al., 2009). These 
difficulties necessitate the discovery of new antifungal agents in order to increase the 
spectrum of activity against Candida spp. There is an increasing acceptance of herbal 
medicine as an alternative form of health care (Shai et al., 2008). Abundant herbs or 
plant base isolated drugs are widely used as antibacterial or antifungal agent 
(Katerere et al., 2003). Therefore, these caused an interest to evaluate the antifungal 
activity of Hymenocallis littoralis in this study.  
The importance of antioxidant to human’s health was realized in 1960s with 
the publications of vitamins, flavonoids and ascorbic acids’ effects on cancers and 
common cold (Matough et al., 2012). Currently, there is an upsurge of interest in 
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phytochemicals as a potential new source of natural antioxidant (Tawaha et al., 
2007). Innumerable herbal medicine  have  been  reported  to  exhibit antioxidant  
activity,  including  Ocimum  sanctum,  Piper cubeba  Linn., Allium sativum  Linn., 
Terminalia bellerica, Camellia  sinensis  Linn.,  Zingiber  officinale  Roscoe  and 
several  Indian  and  Chinese  plants (Khalaf et al., 2008). However there is no report 
on the antioxidant property on Hymenocallis littoralis plant. Therefore, antioxidant 
activity was carried out for this plant using ferric reducing antioxidant power 
(FRAP), total phenolic assay, total flavonoid content and DPPH radical scavenging 
capacity activity protocols. 
 Wound healing property of Hymenocallis littoralis extract was undertaken in 
this study. Fascinatingly, this exploration was carried out because Aloe vera is the 
only plant which use for the study of wound healing using cultured-based, animal 
and human based studies (Krishnan, 2006). Currently, there are reports on anticancer 
property of Hymenocallis littoralis extract (Idso et al., 2000; Ingrassia et al., 2008) 
but there are no reports on the wound healing properties. Thus, bulb, anther, stem, 
leaves, flower and root’s crude extracts were subjected to the wound healing 
assessment using human foreskin fibroblast cell line (Hs27). Fibroblast cells are 
mainly involved in the synthesis and deposition of the extracellular matrix in wound 
healing process (Thakur et al., 2011). Hence, the human fibroblast in vitro model is 
essential to correlate the contractile events of wound (Margaret et al., 1998; Thakur 
et al., 2011). 
Brine shrimp lethality assay is well known assay for the determination of 
toxicity in various materials including plant extracts (McLaughlin et al., 1998), 
pesticides (Barahona and Sanchez-Fortun, 1999), cytotoxicity testing of dental 
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materials (Pelka et al., 2000) and others (Carballo et al., 2002). There are numerous 
data presented for the correlation between brine shrimp and cytotoxicity assay 
(McLaughlin et al., 1998). Hymenocallis littoralis possess effectual anticancer 
activity in various cancerous cell lines (Gabrielsen et al., 1992; Ivanov et al., 2009). 
In this study, the bulb, anther, stem, leaves, flower and root’s crude extracts were 
used for the brine shrimp assay.  
In natural product research, large amount of plant biomass is required to 
provide enough bioactive compounds (Sidik, 2008). Due to natural variability, it is 
an increasing exertion to obtain adequate plant material from single source (Sidik, 
2008). Many efforts have developed feasible method for the production using 
micropropagation technique. Micropropagation is a technique using plant 
meristematic tissue to propagate the plant asexually under in vitro condition (Yew et 
al., 2010). The significant advance in micropropagation led to the establishment of 
callus and cell suspension culture of various plants species. This promote for the 
evaluation of the biological activities and production of selected valuable secondary 
metabolites. Consequently, the bulb was used to propagate callus and shoot of this 
plant via in vitro technique.  
High performance liquid chromatography (HPLC) is a superior precision, 
high resolution and has the capacity to analyze thermally labile and non-volatile 
compounds from plant extracts (Naumovski et al., 2010). Lycorine is the compound 
with the widest spectrum of biological activities isolated from Hymenocallis 
littoralis. It has antiviral, cytotoxicity, antimalarial and anti-inflammatory activities 
(Abou-Donia et al., 2008a). In this study, lycorine compound was used as a standard 
marker to compare the quantity in both wild plant and tissue culture samples. This is 
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to demonstrate the utility of micropropagation techniques in current plant tissue 
culture epoch.  
Concisely, the bulb, anther, stem, leaves, flower and root’s crude extracts 
were subjected to various standard protocols to determine the pharmacological 
properties of the plant extracts. These pharmacological findings may assist in the 
development of an herbal based therapy in the future.  
 
1.1 OBJECTIVES 
The objectives of this research project are: 
 To identify of the anti-Candida activity of the Hymenocallis littoralis plant 
extracts against Candida albicans, 
 To determine of the antioxidant properties of the Hymenocallis littoralis plant 
extracts, 
 To detect the cytotoxicity level of the Hymenocallis littoralis plant extracts using 
brine shrimp lethality assay, 
 To study the wound healing properties of the Hymenocallis littoralis plant 
extracts, 
 To establish of the in vitro shoot and callus initiation for the Hymenocallis 
littoralis, 
 To develop HPLC method for the determination of lycorine content in the wild 
and tissue culture Hymenocallis littoralis plant. 
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1.2 RESEARCH FLOW 
Hymenocallis littoralis’s bulb, flower, anther, leaves, stem, roots were 
extracted using sonication method via methanol solvent to obtain the crude 
methanolic extracts. This crude extract was subjected to few pharmacological 
screening using various standard methods (Chapter 2: Materials and Methods) for 
anti-Candida, antioxidant, brine shrimp lethality evaluation and wound healing 
activity. As for the in vitro micropropagation technique, Hymenocallis littoralis’s 
bulb meristematic tissue was used to establish the callus and shoot cultures. Finally, 
high performance liquid chromatography (HPLC) was used to develop a method to 
detect lycorine content in Hymenocallis littoralis extract and compared the presences 
of lycorine in the wild and tissue cultures extracts. Lycorine is one of the major 
phytochemical substances isolated from the Hymenocallis littoralis plant.  The 
research flow for this study is briefly illustrated in Figure 1.1.  
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Figure 1.1: Research flow for the pharmacology evaluation, establishment of 
tissue culture and lycorine determination using HPLC method on 
Hymenocallis littoralis plant. 
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CHAPTER 2.0 
LITERATURE REVIEW 
 
2.1 Importance of Plant Secondary Metabolites  
In the 21
st
 century, herbal medicines are gaining importance in mainstream 
human healthcare (Sen et al., 2011). A greater number of people are seeking herbal 
remedies which are free from side effects compared to synthetic chemical medicines 
(Dubey et al., 2004). The western population are considering for natural medications 
due to the adverse side effects of synthetic drugs (Gijtenbeek et al., 1999; Johnson 
and William, 2002; Dubey et al., 2004). 
It is estimated that about 80 % of the world population have faith in 
traditional medicine particularly from plant based drugs (Dubey et al., 2004). This is 
due to the unmatched availability of secondary metabolites diversity in natural 
products, either pure compounds or as standardized plant extracts (Cos et al., 2006). 
Total of 20,000 plant species were used for medicinal purposes are reported by 
World Health Organization (WHO) for the year 2005 (Gullece et al., 2006). Sahoo et 
al. (2010) reported that 25 % of the drugs prescribed worldwide are derived from 
plants with total of 121 active compounds. There are 252 drugs in WHO’s essential 
medicine list and out of it 11 % is entirely from plant origin (Sahoo et al., 2010). 
From 2000 to 2005, annual sales for traditional medicines increased from 
US$ 385 million (RM 1 billion) to US$ 1.29 billion (RM 4.5 billion) in globally 
(Aziz and Tey, 2009).  This transformation is because the herbal products are non-
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toxic, at affordable prices, have less side effects, (Dubey et al., 2004; Sharma et al., 
2008) possess better tolerance and are globally competitive (Sen et al., 2011) 
compared to modern synthetic medicines. 
Plants have wide range of secondary metabolites with abundant 
pharmacological properties. Numbers of plant secondary metabolites such as 
flavonoids, alkaloids, saponins, phenolics and terpenes have been used widely as 
antifungal, antibacterial, anticancer, antimalarial and antiviral agents (Ncube et al., 
2008). The flavonoid rich extracts from Scutellaria baicalensis roots have been 
proven to exhibit anti-proliferative effects on various cancer cell lines (Scheck et al., 
2006). Papavarine is a benzylisoquinoline alkaloid that has inhibitory effect on 
several viruses and idoquinoline alkaloid from Cryptolepsis sanguinolenta exhibits 
activity against number of gram negative bacteria and yeast (Silva et al., 1996; 
Ncube et al., 2008).  
Plant-derived products became a primary choice for biological and 
pharmacological researchers to investigate the medicinal properties of the herbal 
plants. Wide category of researchers including ethno-pharmacologist, botanist, 
microbiologist, and natural product chemist are extensively searching for 
pharmacologically active phytochemicals from plants (Tanaka et al., 2006). In India, 
only 7500 species from 17 000 species of higher plant are known for their medicinal 
values (Sen et al., 2011).  
Malaysia has been awarded as the world’s 12th Mega Biodiversity which is 
rich in flora and fauna (Ang, 2004) and blessed with an abundance of varied 
medicinal plants. The most common Malaysian plants undergoing extensive research 
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are Eurycoma longifolia, Labisia pumila, Andrographis paniculata, Orthosiphon 
stamineus, Centela asiatica and so on (Jamal, 2006). However, there are numerous 
species especially under ornamental plants which are not yet proven scientifically for 
its pharmacological activities. Thus, it will be of great benefit for the society at large 
to study the biological and pharmacological properties of these plants especially 
Hymenocallis littoralis. 
 
2.2 Hymenocallis littoralis plant  
Hymenocallis littoralis Salisb. is from Amaryllidaceae family. The 
plant’s description is as bellow:  
Kingdom : Plantae 
Division : Angiospermae 
Class : Monocotyledoneae 
Order : Asparagales 
Family : Amaryllidaceae 
Genus : Hymenocallis 
Species : littoralis 
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Alkaloid is a member of a large group of secondary metabolites which is 
produced in Amaryllidaceae plant species. Many alkaloids possess potent 
pharmacologic effects. From ancient time, numbers of alkaloids from 
Amaryllidaceae plants extracts have been widely used in scientific investigation. The 
phytochemical constituents of Hymenocallis salisb. genus was studied during 1920 
and cause for the isolation of lycorine compound. This plant is common but it 
possesses great importance especially to mankind. The odor of Amaryllidaceae plant 
flowers has been highly valued in the fragrance industry. Volatile compounds from 
these plants are given more interest because of their allelochemical importance as 
defensive compounds, insect repellents, attractants, and their role in ecological 
balance (Abou-Donia et al., 2008b). 
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Figure 2.1: Hymenocallis littoralis. Scale bar (1:5cm) 
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2.2.1 Physiological Characteristics of Hymenocallis littoralis 
Hymenocallis littoralis is a bulbous perennial herb which can grow up to 60 
to 70cm (36 inches). The leaves of this plant are fleshy, dark green and glossy. The 
shape of the leaves is narrowly lanceolate. It is 0.5 to 1.0 meter long and 6 to 7 cm 
wide (Shields, 2006). The plant’s scape is erect, solid and slightly compressed. It is 
about 0.5 m tall. At the top of the scape, there are few to many sessile and umbellate 
flowers. The bulb of the plant is 7-10 cm (3-4 inches) in diameter. With age, the bulb 
develops a neck that reaches 4-5cm in diameter (up to 2 inches) (Shields, 2006). The 
flowers are large, white, vanilla scented and sessile flowers. Hymencallis littoralis 
grows well in normal room temperature for most of the year and needs high humidity 
(Grossi, 2007).  
2.2.2 Phytochemistry of Hymenocallis littoralis perennial herb 
Hymenocallis littoralis is rich in alkaloids. A chromatographic study of the 
qualitative composition of the total material isolated using thin-layer chromatography 
in a fixed layer of type KSK silica gel with various systems of solvents showed the 
identical qualitative compositions of the alkaloids of the epigealand hypogeal part of 
the plant (Lin et al., 1995).  Lycorine is the dominant in Hymenocallis littoralis plant 
extract. These alkaloids are contributing as major role in the pharmacological effects 
(Lin et al., 1995).  
There are also other alkaloids that have been isolated from this plant. The 
names of the isolated compounds are Lycorine (dominant in Hymenocallis littoralis’ 
bulb), Narciclasine (bulb), Lycoricidine (7-deoxynarciclasine) (bulb), Pancratistatin 
(bulb and roots in small extent), trisphaeridine (from bulb with roots), Tazettine, 
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galanthamine, 7,4'-dihydroxy-8-methylflavan (stem), Hippeastrine (bulb), Littoraline 
(bulb), Haemanthamine (bulb), pretazettine (bulb), macronine (bulb), homolycorine 
(bulb), lycorenine (bulb), O-methyllycorenine (bulb), Lycoramine (bulb), 
Demethylmaritidine (bulb), Vittatine (bulb) and 5,6-dihydrobicolorine (Ismine) 
(bulb) (Abou-Donia et al., 2008b). 
 
 
 
 
 
 
 
 
 
 
 
 
15 
 
               
  
 
     
 
Figure 2.2: Few isolated compounds from Hymenocallis littoralis (Abou-Donia et 
al., 2008a). 
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2.2.3 The Therapeutic Importance of Hymenocallis littoralis  
2.2.3.1 Free radical scavenging activity 
Free radicals increases the risk for occurs more than 30 different diseases in 
human body system (Aruoma, 1998).  A compound known as 7, 4’-dihydroxy-8-
methylflavan was isolated from Hymenocallis littoralis stem. The compound was 
subjected to free radical scavenging activity using DPPH spectrophotometric assay. 
The radical scavenging activity of 7,4’-dihydroxy-8-methylflavan (320 µM) was 
found to be weaker than quercetin but equipotent to butylhydroxytolune (BHT) (Ioset 
et al., 2001).  
2.2.3.2. Antiviral properties 
Two important alkaloids, lycoricidine and pancratistatin that were isolated 
from Hymenocallis littoralis show strong RNA anti-viral activity (Gabrielsen et al., 
1992). Pancratistatin demonstrated significant in vitro antiviral activity against 
Japanese encephalitis, yellow fever and dengue-type 4 (Gabrielsen et al., 
1992). Moreover, Gabrielsen et al. (1992) reported the plant activity against RNA-
containing flaviviruses and bunyaviruses namely Punta Toro and Rift Valley fever. 
Lycorine exerts antiviral effects on several RNA and DNA viruses (Fennell and 
Staden, 2001). The effect is accomplished via delaying virus production and 
decreasing the amount of virus by blocking viral protein synthesis (Ieven et al., 1983; 
Fennell and Staden, 2001), possibly at the level of termination (Vrijsen et al., 1986; 
Fennell and Staden, 2001). Lycorine pronounces antiviral activity against 
poliomyelitis, coxsackie and herpes type I viruses (Harborne and Baxter, 1993; 
Fennell and Staden, 2001). This compound has stopped the production of the 
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poliovirus via inhibiting the precursors of poliovirus and poliopeptidase (Ghosal et 
al., 1985; Fennell and Staden, 2001). Littoraline alkaloid from this plant shows an 
inhibitory action towards HIV reverse transcriptase (Lin et al., 1995).  
Lycorine exhibit positive effects against many viruses such as human 
immunodeficiency virus (HIV-1), severe acute respiratory syndrome-associated 
coronavirus (SARS-CoV), poliovirus, coxsackie virus, measles virus, herpes simplex 
virus type I (HSV-I) (Ieven et al., 1983; Szlavik et al., 2004; Li et al., 2005) and 
vaccinia small pox virus (Deng et al., 2007; McNulty et al., 2009). However, 
Littoraline shows weakly inhibited HIV-1 reverse transcriptase (IC50 = 142.0 
mg/mL) activity (Lin et al., 1995). 
2.2.3.3. Anticancer properties 
The tropical spider lily has been known to has antitumor property since in 
ancient time (Idso et al., 2000). Pancratistatin exhibits a vast anticancer activity 
against various cell lines (Griffin et al., 2007).  
Pancratistatin, a natural compound isolated from the Hawaiian spider lily 
(Hymenocallis littoralis) displayed potent cytotoxicity against human tumor cell lines 
(Pettit et al., 1993b; Griffin et al., 2007). Pancratistatin is proved to be effective (38-
106% life extension at 0.75-12.5 mg/kg dose levels) against the murine P-388 
lymphocytic leukemia. PST also markedly inhibited (ED50, 0.01 µg/mL) growth of 
the P-388 in vitro cell line and in vivo murine M-5076 ovary sarcoma (53-84% life 
extension at 0.38-3.0 mg/kg) (Pettit et al., 1986; Idso et al., 2000).  
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Further investigation reveals that, pancratistatin possess cytotoxicity against 
60 human cancer cell lines, demonstrating highest efficiency against melanoma 
subpanel lines and active for certain brain, colon, lung and renal cancer cell lines 
(Pettit et al., 1993b; Idso et al., 2000). The pancratistatin compound exhibits selective 
toxic effects to cancer cells and normal cells at micro-molar doses (Kekre et al., 
2005; Griffin et al., 2007). This compound reacts to the cell by affecting 
mitochondrial function and inducing apoptosis in malignant cell lines (McLanchlan 
et al., 2005; Griffin et al., 2007).  
Two other alkaloids that also play an important role in anticancer properties 
are lycorine and haemanthamine. Both were potent in vitro cytotoxicity against a 
battery of human cancer cell lines such as human breast cancer, human colon cancer 
and human lung cancer (ED50 values of 0.2-5.0 µg/mL) (Lin et al., 1995). Lycorine 
inhibits the in vivo growth of a murine ascite tumor and reduce the viability of in 
vitro grown tumor cells (Ghosal et al., 1985). Lycorines also inhibits the synthesis of 
DNA and proteins in murine cells (Ghosal et al., 1985).  
2.2.3.4. Antibacterial and antifungal properties 
Antibacterial and antifungal screenings of H. littoralis were carried out using 
the agar-diffusion technique against the Gram-positive bacterium Staphylococcus 
aureus, the Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa, 
and the fungus Candida albicans. The petroleum ether extract of H. littoralis showed 
antibacterial activity against Gram-positive Staphylococcus aureus and Gram-
negative Pseudomonas aeruginosa, but no activity against Escherichia coli and 
Candida albicans (Abou-Donia et al., 2008b). The corresponding minimum-
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inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) 
values were 15.6 and 62.5 mg/mL (S. aureus), and 250 and 500 mg/mL (P. 
aeruginosa), respectively (Abou-Donia et al., 2008b). Lycorine, pseudolycorine, 
narciclasine and pretazettine compounds exhibit antifungal activity against 
Saccharomyces cerevisiae (Giudice et al., 2005) and inhibiting the protein synthesis 
and blocking peptide bond formation in eukaryotic cells (Cordell, 1981; Ghosal et 
al., 1985; Fennell and Staden, 2001).  
2.2.3.5 Anti-parasitic properties 
Pancratistatin and lycoricidine showed an in vitro anti-parasitic effect against 
a microsporidium causing infections in humans (Quarzane-Amara et al., 2001). The 
anti-parasitic effect of a collection of compounds with anti-mitotic activity has been 
tested on a mammalian cell line infected with Encephalitozoon intestinalis, a 
microsporidian causing intestinal and systemic infection in immune-deficient 
patients (HIV patients) (Weber and Bryan, 1994). 
The anti-parasitic effect was evaluated by counting the number of 
parasitophorous vacuoles detected by immunofluorescence. Two out of 526 
compounds tested show inhibition activity of the infection without affecting the host 
cell. These two compounds are PST and 7-deoxynarciclasine. The 50% inhibitory 
concentrations (IC50) of PST and 7-deoxynarciclasine for E. intestinalis were 0.18 
µM and 0.2 µM, respectively, approximately eightfold lower than the IC50 of these 
same compounds against the host cells (Quarzane-Amara et al., 2001). Electron 
microscopy confirmed the gradual decreases in the number of parasitophorous 
vacuoles and showed that of the two life cycle phases, sporogony was more sensitive 
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to the inhibitors than merogony. Furthermore, the persistence of meronts in some 
cells apparently devoid of sporonts and spores indicated that the inhibitors block 
development rather than entry of the parasite into the host cell. The occurrence of 
binucleate sporoblasts and spores suggests that these inhibitors blocked a specific 
phase of cell division (Quarzane-Amara et al., 2001). 
 
2.2.4. Other pharmacological effects of Hymenocallis littoralis 
The locals believed that the underground stem when boiled and the decoction 
drunk could increase appetite. The whole plant is also pounded for poulticing 
swollen joints and broken bones (Idso et al., 2000). Lycorine proved to be a 
powerful feeding deterrent against highly poyphagous insect, the desert locust 
(Singh and Pant, 1980) and insect anti-feedant activity (Evidente et al., 1986).  
Lycorine suppressed tumor cell growth and reduced cell survival via cell 
cycle arrest and induction of apoptosis for the in vitro mode of action in a leukemia 
(HL-60) cell line model (Liu et al., 2004; McNulty et al., 2009). Lycorine also 
investigated on severe combined immune-deficiency (SCID) mice inoculated with 
HL-60 cells and suppressed tumor cell growth and increased survival rate of treated 
animal without any adverse effects (Liu et al., 2007). This compound also arrest the 
cell cycle progression and exhibit apoptosis on multiple myeloma (KM3) cells (Li et 
al., 2007b; McNulty et al., 2009).  
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2.3 Antifungal Activity  
2.3.1 Rise of Fungal Infections in Humans 
Fungal infection in human beings is remains a therapeutic problem despite 
there is availability of antifungal ointments, lotions, capsules, powders and paints 
(Yigit et al., 2008). The infection has increased dramatically over the past few 
decades. The fungal infections are often challenging to diagnose, severe, swiftly 
progressive and refractory to the therapy (Yigit et al., 2008).  
 
2.3.2 Common Fungal Infection 
Yeast fungal infections became quite common in immuno-compromised 
hosts, especially in HIV-infected individuals, or in patients given 
immunosuppressive or   broad-spectrum antibiotics (Sanglard, 2002). In recent years, 
Candidiasis become a serious infectious disease commonly in immunologically 
compromised patients (Duarte et al., 2005). 
Candidiasis disease can be acute or chronic, superficial or deep infection to 
human beings (Prabhakar et al., 2008). This disease mostly knocks in patients who 
are predisposed to an overgrowth of their own yeast flora (Prabhakar et al., 2008). 
The oropharyngeal candidiasis occurs to diabetes mellitus patients, to those receiving 
antibacterial antibiotics and infected with HIV 1 and HIV 2 (Kwon-Chung and 
Bennet, 1992). Among the various species, Candida albicans is the most causative 
agent for the candidiasis infection (Edwards, 1995; Douglas, 2003; Naeini et al., 
2009).  
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2.3.3 Candida albicans 
Candida is a thin walled small cell and grouped under yeast family (Najafi 
and Sadeghi-Nejad, 2011). Candida albicans is an opportunistic pathogen that can 
cause local and systemic infections in those undergoing persistent antibiotic 
treatment (Duarte et al., 2005). It is a yeast fungus that resides on skin and mucosa of 
immune-competent individuals (Fringuelli et al., 2002) and causes oral, vaginal and 
systemic infections (Lyons and White, 2000). 
There are several antifungal drugs are available in the markets for the 
treatment of Candida infections. Amphotericin B (AmB), 5-flouorocytosine (5-FC), 
Azoles group antifungal agent such as fluconazole, itraconazole, ketoconazole, 
miconazole and clotrimazole, are the common antifungal drugs for the treatment of 
Candida illnesses (Sanglard, 2002). These drugs are divided into two groups as 
topical antifungal (miconazole, nystatin, tioconazole and clotrimazole) and oral drugs 
(fluconazole and AmB) (Najafi and Sadeghi-Nejad, 2011). 
 
2.3.4 Failure of The Current Antifungal Drugs 
Currently a lot of antifungal drugs are available yet there are rising out breaks 
for Candida species infections. There are few causes for the failure of the 
suppression of Candida infections. Certainly the toxic effects of the available 
antifungal drugs, the high cost of drugs, limited number of antifungal drugs for the 
illness, resistance and relapse of Candida infections are the main causes for the 
failure (Klepser, 2001; Khan et al., 2003; Runyoro et al., 2006; Naeini et al., 2009). 
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Currently, the widespread and incorrect use of azole group and Amphotericin 
B antifungal has led to emergence of resistance in common pathogenic fungi 
(Graybill, 1996; Masoko et al., 2007). Several studies shows the Candida species 
resistance towards amphotericin B, fluconazole, flucytosine, itraconazole and 
ketoconazole (Hawser and Douglas, 1995; Chandra et al., 2001; Lewis et al., 2002; 
Al-Fattani and Douglaas, 2004). This led to the increases of opportunistic infections 
especially with Acquired Immunodeficiency Syndromes (AIDS) patients and 
individuals on immunosuppressive chemotherapy (Maregesi et al., 2008).  
2.3.4.1 Amphotericin B 
The widespread and over uses of these drugs lead Candida to evolve 
resistance mechanism against to the antifungal medications (Najafi and Sadeghi-
Nejad, 2011). AmB is a strong fungicidal drug and its primary mode of action is to 
bind ergosterol in the membrane bilayer. This leads to the production of pore-like 
structure on the membrane and the leakage of vital cytoplasmic components such as 
mono and divalent cations (Najafi and Sadeghi-Nejad, 2011). Nonetheless, clinical 
isolates of Candida from AIDS patient shows resistance towards this drug (Kelly et 
al., 1994; Najafi and Sadeghi-Nejad, 2011). The drug resistance often associates with 
the alteration of membrane lipids and lack of ergosterol content associate in cell 
membrane (Dick et al., 1980; Najafi and Sadeghi-Nejad, 2011).  
2.3.4.2 5-Fluorocytosine (5-FC) 
 5-FC displayed a good in vitro and in vivo antifungal activity (Polok, 1990). 
Cytosine deaminase in Candida cells deaminated the 5-FC into 5-fluorouracil (5-
FU). This 5-FU can be incorporate into RNA and lead to miscoding protein. 
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Moreover, can be converted to a deoxynucleoside which inhibits thymidilate 
synthase and thereby DNA synthesis (Coleman et al., 1998; Sanglard, 2002). 
Conversely, the lack of cytosine permease enzyme implication in the metabolism of 
5-FC and deregulation of the pyrimidine biosynthetic pathway could lead to the 
resistance of the 5-FC drug (Sanglard, 2002).  
2.3.4.3 Azole groups 
 Azole groups antifungal (ketoconazole, miconazole, fluconazole, 
clotrimazole and itraconazole) have a cytochrome P450 (ERG11 gene) as a common 
cellular target in yeast or fungi (White et al., 1998). The unhindered nitrogen ring in 
the drug binds the heme iron of Erg11p and inhibiting the enzymatic reaction. The 
first case of resistance was reported on Candida albicans due to the prolonged 
therapy with ketoconazole and miconazole (White et al., 1998). The extended 
treatment cause mutation in the gene encoding for Erg11p and trigger conformational 
changes in the binding azole drugs (Lamb et al., 1998; Sanglard, 2002).   
 
2.3.5 New Antifungal Exploration 
The different morphological forms and differential sensitivity necessitating 
enhanced doses of antifungals for Candida albicans (Mukharjee et al., 2003). Many 
antifungal drugs have limited use due to the side effects and emergence of antibiotic 
resistant to  human pathogenic fungi (Maregesi et al., 2008). Thus, there is a need of 
searching more new substances which could act host friendly (Zore et al., 2011).  
